missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ RNaseOUT™ Recombinant Ribonuclease Inhibitor

Catalog No. 10777019
Encompass
Change view
Click to view available options
Quantity:
5000 Units
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
10777019 5000 Units
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 10777019 Supplier Invitrogen™ Supplier No. 10777019
Only null left

Protects mRNA and improves total cDNA yields.

RNaseOUT Recombinant Ribonuclease Inhibitor is a potent noncompetitive inhibitor of pancreatic-type ribonucleases such as RNase A and is used to avoid RNA degradation in a variety of applications. It is an acidic protein with a molecular weight of ∼52 kDa that inhibits RNase A, RNase B, and RNase C.

The robust molecular structure of the RNaseOUT™ inhibitor together with a very high binding affinity for pancreatic-type RNases ensures superior protection of RNA from degradation making RNaseOUT™ highly effective and reliable in various molecular biology applications.

Features

  • Stable under prolonged reaction conditions—effective RNA protection from RNases at:
    • 4°C for at least 96 hours
    • 25°C for at least 96 hours
    • 37°C for 24 hours
    • 50°C for up to 6 hours
  • Oxidation resistant—highly stable and requires low concentrations of DTT to retain RNase inhibiting activity
  • Wide activity temperature range—maintains full activity from 4°C to 55°C
  • Superior quality—stringent quality control and industry leading manufacturing process

Applications

  • In vitro transcription and translation
  • CRISPR guide RNA production
  • RNA purification
  • cDNA synthesis
  • RT-PCR
  • RT-LAMP
  • RNA-seq
  • RNA modification and labeling

Source

Purified by affinity chromatography from E. coli expressing a cloned porcine gene.

Performance and quality testing

  • SDS-PAGE purity
  • Endo-deoxyribonuclease assay
  • Protein concentration
  • Specific activity
  • Performance evaluated by RT-PCR

Unit definition

One unit inhibits 5 ng of RNase A by 50% using cytidine 2', 3' cyclic monophosphate (cCMP) as the substrate.

Unit reaction conditions

100 mM Tris-acetate (pH 6.5), 1 mM EDTA, 0.2 mM cCMP, 2 μg RNase A in 1 mL from 0 to 10 min at 25°C

Specifications

Concentration 40 U/μL
Content And Storage Store at -20°C. Avoid exposing product to frequent changes in temperature. RNaseOUT™ Ribonuclease Inhibitor requires 1 mM DTT to maintain activity.

The product is guaranteed for 6 months from date of purchase unless otherwise stated in the product documentation.
Product Line RNaseOUT
Quantity 5000 Units
Which components of the SuperScript III First Strand Synthesis System for RT-PCR are available for purchase separately?

The following components are available as stand-alone items:

- Superscript III Reverse Transcriptase (Cat. Nos. 18080093, 18080044, 18080085)
- Oligo (dT)20 Primer (Cat. No. 18418020)
- Random hexamers (Cat. No. 48190011)
- 10 mM dNTP Mix (Cat. Nos. 18427013, 18427088)
- RNAseOUT Recombinant Ribonuclease Inhibitor (Cat. No. 10777019)
- E. coli RNAse H (Cat. Nos. 18021014, 18021071)

What does RNaseOUT Recombinant RNase Inhibitor do?

The inhibitor acts as a safeguard against degradation of target RNA due to ribonuclease contamination of the RNA preparation.

What is the concentration of RNaseOUT Recombinant Ribonuclease Inhibitor in Units/microL?

RNaseOUT Recombinant Ribonuclease Inhibitor is provided at a concentration of 40 U/µL.

What is the temperature limitation of RNaseOUT Recombinant Ribonuclease Inhibitor (Cat. No. 10777019)?

RNaseOUT Recombinant Ribonuclease Inhibitor (Cat. No. 10777019) unit reaction conditions are defined at 25 degrees C. The upper temperature limit for full functionality is 40 degrees C. The enzyme half-life is decreased as temperatures increase above 40 degrees C. There is some residual activity up to 50-55 degrees C but heating at 65 degrees C will inactivate the enzyme. As RNaseOUT can be used in various applications like cDNA synthesis, RT-PCR, and in vitro transcription, the recommendation is to follow the temperature settings required for the respective method.

I am having trouble performing PCR amplification after DNA isolation with RNAlater-treated samples. Does RNAlater have an impact on downstream PCR applications?

RNAlater should not impact downstream PCR amplification as long as the sample has been properly cleaned before proceeding with DNA isolation, as stated in the RNAlater Stabilization Solution manual (https://assets.thermofisher.com/TFS-Assets/LSG/manuals/7020M.pdf) on page 7.

What is the difference between RNAlater Stabilization Solution and RNaseOUT Recombinant Ribonuclease Inhibitor? When do I use one over the other?

RNAlater Stabilization Solution stabilizes and protects cellular RNA in intact, unfrozen tissue samples, eliminating the need to immediately process tissue samples or to freeze samples in liquid nitrogen for later processing. In other words, it is an RNA preserving reagent.

RNaseOUT Recombinant Ribonuclease Inhibitor is a potent non-competitive inhibitor of pancreatic-type ribonucleases such as RNase A, and is used to avoid RNA degradation in a variety of applications such as cDNA synthesis, RT-PCR, and in vitro transcription and translation. RNAseOUT inhibits RNase A, RNAse B, and RNAse C. In other words, RNaseOUT Recombinant Ribonuclease Inhibitor is mainly used in an assay to prevent RNA degradation.


For Research Use Only. Not for use in diagnostic procedures.